Marksure Pharma Private Limited
About Marksure Pharma Private Limited
Data last updated:
Marksure Pharma Private Limited is a private limited company based in Sambhal, Uttar Pradesh, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 20 January 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24230UP2020PTC125905. Its GSTIN is 09AANCM2549Q1ZK (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandhya and Sumit Kumar Varshney.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Giriraj Kishor 25 Chaudhary Sarai Sambhal, Uttar Pradesh, India – 244302.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.72 Lakh, a decline of 74% compared to the previous year. For the same year it recorded a net profit of ₹31,364 (net margin 18.3%) and EBITDA of ₹1.56 Lakh (EBITDA margin 90.7%). Revenue has declined at a compounded annual rate (CAGR) of 43% over three years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Giriraj Kishor 25 Chaudhary Sarai Sambhal, Uttar Pradesh, India – 244302
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Marksure Pharma Private Limited
The main business activity of Marksure Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Marksure Pharma Private Limited FY 2025 filings available
Marksure Pharma Private Limited reported revenue of ₹1.72 Lakh (down 74% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Marksure Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 43% over three years, including a 74% fall in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Marksure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.56 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹31,364 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Marksure Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 90.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 18.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Marksure Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Marksure Pharma Private Limited
Marksure Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhya | Director | 20 Jan 2020 | 6 Years 9 Months | Current |
| Sumit Kumar Varshney | Director | 20 Jan 2020 | 6 Years 9 Months | Current |
Peer Comparison of Marksure Pharma Private Limited
Marksure Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sri Ramana Health Care Private Limited | ₹1.73 Lakh (FY 2016) | •••• | •••• | -98.0% | •••• | Chennai, Tamil Nadu, India |
| PMB Life Sciences Private Limited | ₹1.73 Lakh (FY 2020) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Ajwa Care Private Limited | ₹1.72 Lakh (FY 2024) | •••• | •••• | -9.0% | •••• | Nalanda, Bihar, India |
| Maxkind Laboratories Private Limited | ₹1.72 Lakh (FY 2024) | •••• | •••• | 94.0% | •••• | Jaunpur, Uttar Pradesh, India |
| Genores Biotech Private Limited | ₹1.72 Lakh (FY 2024) | •••• | •••• | -100.0% | •••• | Panvel, Maharashtra, India |
| Marksure Pharma Private Limited this company | ₹1.72 Lakh (FY 2025) | •••• | •••• | -74.0% | •••• | Sambhal, Uttar Pradesh, India |
| Citifrag India Private Limited | ₹1.71 Lakh (FY 2025) | •••• | •••• | -63.0% | •••• | Hyderabad, Telangana, India |
| Param Herbal Remedies Private Limited | ₹1.71 Lakh (FY 2020) | •••• | •••• | -71.0% | •••• | Punjab, India |
| Magnicare Pharma Private Limited | ₹1.7 Lakh (FY 2018) | •••• | •••• | 36.0% | •••• | Pune, Maharashtra, India |
| Grosswell Health Care Private Limited | ₹1.7 Lakh (FY 2023) | •••• | •••• | 136.0% | •••• | Akbarpur, Uttar Pradesh, India |
| Habitus Pharma Private Limited | ₹1.7 Lakh (FY 2025) | •••• | •••• | •••• | Amritsar, Punjab, India |
Peers are the five companies nearest above and the five nearest below Marksure Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Marksure Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Marksure Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jan 2023 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Marksure Pharma Private Limited
Employment history and EPFO contributions of people linked to Marksure Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Marksure Pharma Private Limited
Marksure Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Sandhya was appointed as Director on 20 Jan 2020.
Credit Ratings, Litigation & Regulatory Alerts for Marksure Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Marksure Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Marksure Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Marksure Pharma Private Limited
Marksure Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCM2549Q1ZK | Uttar Pradesh | Active | 06 Sep 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Marksure Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marksure Pharma Private Limited
Marksure Pharma is an active private limited company based in Sambhal, Uttar Pradesh, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 20 January 2020 (6+ years old) and is registered under CIN U24230UP2020PTC125905.
Marksure Pharma reported revenue of ₹1.72 Lakh for FY 2025 (down 74% YoY).
Marksure Pharma has 2 current directors:
- Sandhya - Director
- Sumit Kumar Varshney - Director
Marksure Pharma reported a net profit of ₹31,364 (net margin 18.3%) and EBITDA of ₹1.56 Lakh (EBITDA margin 90.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Marksure Pharma is -43% over three years. In the latest year (FY 2025) revenue fell 74%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Marksure Pharma is 09AANCM2549Q1ZK, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Marksure Pharma is U24230UP2020PTC125905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marksure Pharma was incorporated on 20 January 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Marksure Pharma by revenue are Sri Ramana Health Care Private Limited, PMB Life Sciences Private Limited, Ajwa Care Private Limited, Maxkind Laboratories Private Limited, Genores Biotech Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sandhya was appointed as Director on 20 Jan 2020. Sumit Kumar Varshney was appointed as Director on 20 Jan 2020.
The registered office of Marksure Pharma is at CO Giriraj Kishor 25 Chaudhary Sarai Sambhal, Uttar Pradesh, India – 244302.